Ligand Pharmaceuticals LGND Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's interest coverage?
- Ligand Pharmaceuticals (LGND) reported interest coverage of 16.9× in Q1 2026.
- How has Ligand Pharmaceuticals's interest coverage changed year-over-year?
- Ligand Pharmaceuticals's interest coverage increased by 202.8% year-over-year, from -16.4× to 16.9×.
- What is the long-term trend for Ligand Pharmaceuticals's interest coverage?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's interest coverage has grown at a 44.8% compound annual growth rate (CAGR), from 1.4× to 8.7×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.